U.S. Ambulatory Gastroenterology Devices Market

Market Outlook

By 2035, the U.S. Ambulatory Gastroenterology Devices Market is projected to reach approximately USD 15.65 billion, expanding at a CAGR of 10.25% during the forecast period 2026–2035. The market is estimated at USD 5.90 billion in 2025, following historical expansion from approximately USD 3.97 billion in 2021, USD 4.43 billion in 2022, USD 4.87 billion in 2023, and USD 5.36 billion in 2024. Values in this report are expressed in USD billions.

The market sizing represents device, equipment, consumable, reprocessing, diagnostic, and associated technology revenue generated through U.S. ambulatory gastroenterology workflows, including freestanding ambulatory surgery centers, hospital outpatient endoscopy departments, physician-owned endoscopy centers, gastroenterology practices, and other non-inpatient procedural settings. Market estimates are developed through procedure-volume modeling, installed-base replacement assumptions, consumable utilization, average selling prices, technology penetration, and site-of-care allocation.

Ambulatory gastroenterology is becoming one of the most economically important areas of U.S. outpatient procedural medicine. Colonoscopy, esophagogastroduodenoscopy, biopsy, polypectomy, gastrointestinal bleeding management, dilation, motility testing, reflux diagnostics, endoscopic ultrasound, selected endoscopic mucosal therapies, and increasingly sophisticated therapeutic procedures are being delivered without conventional inpatient admission.

The underlying infrastructure is substantial. The United States had more than 6,400 Medicare-certified ambulatory surgery centers in 2024, while gastroenterology represented one of the two largest single-specialty ASC categories. More than 1,200 facilities billing fee-for-service Medicare were classified as single-specialty gastroenterology ASCs. This established procedural network creates recurring demand for colonoscopes, gastroscopes, visualization processors, insufflation systems, electrosurgery units, biopsy forceps, snares, injection needles, clips, guidewires, dilation systems, reprocessing equipment, leak-testing systems, single-use components, AI-enabled detection technologies, and documentation infrastructure.

Demand is further supported by colorectal cancer screening. Roughly seven in ten U.S. adults aged 50–75 are considered up to date with colorectal cancer screening, while screening recommendations now begin at age 45 for average-risk adults. The expansion of the screening-eligible population provides a durable procedure-volume base for ambulatory colonoscopy. At the same time, rising colorectal cancer incidence among younger adults is increasing clinical attention on earlier diagnosis and surveillance.

The central commercial shift through 2035 will be from conventional endoscopy equipment procurement toward integrated ambulatory GI procedure platforms. Facilities increasingly evaluate technologies according to procedure-room throughput, adenoma detection support, scope turnaround, reprocessing labor, infection-control risk, device uptime, disposable cost per case, anesthesia utilization, physician efficiency, reimbursement, and total contribution margin per procedure.

Introduction

According to the U.S. Ambulatory Gastroenterology Devices Market Report, outpatient gastroenterology has moved beyond being a lower-acuity extension of hospital GI care. It is becoming a distinct procedural ecosystem with its own capital requirements, staffing economics, purchasing behavior, infection-control standards, clinical pathways, and technology priorities.

Digestive disorders create a large recurring care requirement in the United States. Federal healthcare statistics have historically identified tens of millions of physician-office encounters annually in which digestive diseases are the primary diagnosis. More recently, gastrointestinal disorders continue to account for millions of emergency and ambulatory encounters. Colorectal cancer remains particularly important to procedure demand, with close to 148,000 cases reported nationally in 2022 and more than 53,000 deaths recorded in 2023.

Demographics strengthen the long-term outlook. More than 61 million U.S. residents were aged 65 or older in 2024. Aging increases the prevalence of colorectal neoplasia, diverticular disease, dysphagia, GI bleeding, pancreaticobiliary disorders, and multiple chronic conditions requiring diagnostic or therapeutic endoscopy. However, growth is no longer an elderly-patient story alone. Rising colorectal cancer incidence among adults below traditional retirement age, expanded screening eligibility beginning at 45, obesity-related GI disorders, reflux disease, inflammatory bowel disease surveillance, and greater patient preference for convenient outpatient care widen the addressable population.

The ambulatory setting is economically differentiated from acute-care hospitals. A GI ASC must achieve high procedure utilization while managing fixed costs for endoscopy towers, processors, scopes, electrosurgical equipment, reprocessing infrastructure, anesthesia capabilities, IT integration, and service contracts. Consequently, administrators often prioritize predictable cost per case, equipment durability, rapid room turnover, minimal downtime, simplified staff training, and standardized consumable inventory.

Commercial success therefore depends on more than diagnostic performance. Manufacturers increasingly need to demonstrate how their platforms affect the economics of the entire procedure day. A technology that improves lesion visualization but materially slows room turnover can face resistance. Conversely, a higher-priced product may gain adoption when it lowers reprocessing burden, reduces equipment downtime, shortens procedure time, improves quality documentation, or enables procedures that previously required hospital referral.

Key Market Drivers: What’s Fueling the U.S. Ambulatory Gastroenterology Devices Market Boom?

The strongest structural driver is the continued migration of appropriate procedures away from high-cost inpatient environments. U.S. payers, physicians, health systems, and patients have increasingly favored ambulatory care when safety and clinical complexity permit. Medicare-certified ASC supply increased to approximately 6,436 facilities in 2024, continuing a long-term expansion trend. Gastroenterology remains particularly well suited to this model because colonoscopy and upper-GI endoscopy can be standardized into high-throughput procedural workflows.

Medicare economics reinforce the migration. In 2024, approximately 3.4 million fee-for-service Medicare beneficiaries received ASC services. Aggregate Medicare payments to ASCs reached approximately USD 7.5 billion, increasing strongly from the prior year. Although this figure represents all ASC specialties rather than gastroenterology alone, it illustrates the expanding economic importance of freestanding outpatient procedural infrastructure.

Colorectal cancer prevention is the second major demand engine. Close to 148,000 new colorectal cancer cases were reported in the United States in 2022, and the disease remains a leading cause of cancer mortality. Colonoscopy has a distinctive economic position because the procedure can simultaneously screen, diagnose, biopsy, and remove precancerous lesions. Every expansion in screening participation therefore drives demand not only for visualization systems but also for snares, forceps, clips, retrieval devices, injection systems, pathology workflow, reprocessing, and increasingly AI-assisted detection.

The aging population provides another durable driver. More than 61 million Americans were aged 65 or older in 2024. Older adults undergo disproportionately high volumes of colorectal surveillance, evaluation of anemia and bleeding, dysphagia assessment, polyp management, and follow-up of gastrointestinal disease. Higher Medicare Advantage penetration also changes commercial strategy because manufacturers increasingly need to understand payer-provider alignment, physician ownership, ASC contracting, and network-based utilization management.

A fourth driver is the procedural economics of physician-controlled facilities. Gastroenterologists with ownership or financial participation in ASCs have stronger incentives to understand utilization, labor productivity, room turnover, disposable consumption, and equipment service costs. Device companies selling into these facilities encounter purchasing decisions that can be more operationally rigorous than those of traditional departmental capital budgets.

A fifth driver is the expansion of advanced therapeutic endoscopy. Endoscopic mucosal resection, endoscopic suturing, defect closure, hemostasis, complex polypectomy, balloon dilation, stenting, endoscopic bariatric procedures, and selected third-space interventions are increasing the value of each procedure room. Not every advanced case is appropriate for a freestanding ASC, but technology improvements are steadily widening the boundary between routine ambulatory GI and hospital-dependent intervention.

A sixth driver is infection prevention. Flexible endoscopes are complex reusable devices requiring validated cleaning and high-level disinfection. This creates demand for automated endoscope reprocessors, drying and storage cabinets, leak testers, channel-cleaning accessories, tracking software, single-use valves, disposable distal components, and increasingly single-use endoscopes in selected workflows. Infection-control performance has therefore become part of capital procurement rather than a secondary operational consideration.

Finally, reimbursement policy continues to favor outpatient efficiency. For 2026, Medicare increased qualifying ASC payment rates by 2.6% and materially expanded the ASC Covered Procedures List. These policies do not automatically move every GI procedure into an ASC, but they strengthen the broader regulatory framework supporting clinically appropriate outpatient procedural migration.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in ambulatory gastroenterology is moving toward technologies that increase diagnostic yield without materially disrupting procedure throughput.

Artificial intelligence is among the most consequential developments. Computer-aided detection systems can continuously analyze colonoscopy video and alert physicians to suspected lesions. Their commercial relevance is particularly strong in ambulatory centers because quality improvement can be layered onto existing procedure volumes. AI is moving from an isolated software purchase toward an integrated quality-management architecture involving adenoma detection, withdrawal-time monitoring, documentation support, analytics, and eventually longitudinal benchmarking.

Advanced imaging is evolving in parallel. High-definition visualization, enhanced depth of field, narrow-spectrum imaging, contrast-enhancement technologies, improved illumination, and image-processing algorithms are helping endoscopists characterize mucosal abnormalities more efficiently. Premium visualization systems are increasingly positioned around clinical confidence and workflow consistency rather than resolution alone.

Single-use endoscopy represents another important competitive frontier. FDA-cleared disposable gastroscopes, colonoscopes, and duodenoscopes are creating alternatives to conventional reusable platforms. Economics remain procedure-dependent. In high-volume colonoscopy centers, reusable systems can retain a favorable per-case cost structure, while single-use scopes may be attractive for selected cases, overflow capacity, infection-sensitive procedures, emergency availability, low-volume locations, or facilities attempting to reduce reprocessing infrastructure.

Therapeutic endoscopy is also becoming more sophisticated. Endoscopic clips, suturing systems, hemostatic technologies, tissue-resection devices, electrosurgical tools, advanced snares, dilation systems, stents, and endoluminal devices allow clinicians to treat conditions during the same episode in which they are identified. This reduces downstream referrals and can improve the economics of advanced ambulatory GI programs.

Manufacturers are simultaneously redesigning the operational layer surrounding the procedure. Connected scope tracking, automated reprocessing documentation, procedure-room integration, centralized equipment monitoring, digital reporting, inventory analytics, and preventive maintenance can reduce nonclinical friction. For an ASC performing procedures throughout an eight- or ten-hour operating day, minutes of avoidable downtime can materially affect annual economics.

Segmentation Insights

The U.S. Ambulatory Gastroenterology Devices Market is segmented on the basis of product category, procedure type, end user, technology type, and clinical application.

By Product Category

Endoscopy and Visualization Systems

Endoscopy and visualization systems account for a major share of capital spending and include colonoscopes, gastroscopes, duodenoscopes, enteroscopes, endoscopic ultrasound equipment, video processors, light sources, displays, insufflation equipment, pumps, and integrated endoscopy towers. Colonoscopy and upper-GI endoscopy dominate ambulatory installed-base utilization. Replacement decisions typically reflect image quality, compatibility with existing scopes, expected utilization, service coverage, ergonomics, and the ability to support advanced imaging.

Endoscopic Accessories and Disposable Devices

Accessories and disposables form one of the market’s most commercially attractive categories because revenue scales with procedure volume. Products include biopsy forceps, polypectomy snares, injection needles, retrieval nets, guidewires, cleaning accessories, valves, bite blocks, tubing sets, irrigation devices, and specimen-retrieval products. The segment benefits directly from recurring colonoscopy and EGD volumes and is less exposed to long capital replacement cycles.

Therapeutic Gastroenterology Devices

Therapeutic devices include hemostasis clips, electrosurgical accessories, dilation balloons, luminal stents, endoscopic suturing systems, tissue-resection devices, defect-closure technologies, endoscopic bariatric devices, foreign-body retrieval systems, and other endoluminal tools. This category is expected to outperform routine diagnostic equipment because more ambulatory GI centers are building capabilities beyond conventional screening colonoscopy.

Gastrointestinal Functional and Diagnostic Devices

This segment includes esophageal pH monitoring, impedance testing, anorectal manometry, motility systems, breath-testing equipment, capsule-related diagnostic platforms, and other technologies used to evaluate functional GI disorders. Adoption is strongest among large gastroenterology groups capable of integrating office diagnostics with endoscopic referral pathways.

Reprocessing and Infection-Prevention Devices

Automated endoscope reprocessors, drying and storage systems, leak testers, cleaning verification technology, scope-transport solutions, brushes, adapters, tracking systems, and related infection-prevention equipment form a critical infrastructure segment. Buyers increasingly evaluate reprocessing equipment on validated performance, workflow automation, labor requirements, chemical consumption, traceability, and compatibility with endoscope fleets.

By Procedure Type

Colonoscopy

Colonoscopy represents the largest ambulatory procedure segment. Screening, surveillance, diagnostic colonoscopy, biopsy, polypectomy, bleeding assessment, and follow-up of positive stool-based tests create high recurring equipment utilization. Expansion of average-risk screening to adults beginning at age 45 enlarged the eligible population and increased the strategic importance of capacity planning within GI ASCs.

Upper Gastrointestinal Endoscopy

EGD supports diagnosis and treatment of dysphagia, reflux complications, ulcers, anemia, GI bleeding, Barrett’s esophagus, upper-GI tumors, and other conditions. The procedure is highly compatible with ambulatory workflows and provides recurring demand for gastroscopes, biopsy devices, dilation products, hemostasis tools, and imaging technologies.

ERCP, EUS and Pancreatobiliary Procedures

Advanced pancreatobiliary procedures represent a smaller but high-value segment. More than 500,000 ERCP procedures are performed annually in the United States across care settings. Because ERCP patients can require complex anesthesia and post-procedure monitoring, much of this activity remains concentrated in hospitals and sophisticated outpatient departments. Nevertheless, related scopes, accessories, guidewires, stents, balloons, and imaging technologies materially influence the overall ambulatory GI device ecosystem.

Advanced Endoscopic Therapy

Complex polypectomy, endoscopic mucosal resection, defect closure, suturing, hemostasis, dilation, and other therapeutic interventions are expanding the revenue potential of ambulatory endoscopy suites. Centers with experienced physicians and appropriate emergency protocols can retain a broader range of cases rather than transferring every complex intervention to hospital facilities.

GI Functional Testing and Office-Based Procedures

Reflux testing, motility evaluation, anorectal diagnostics, breath testing, and selected office-based procedures provide a complementary revenue stream to procedural endoscopy. These services can strengthen vertically integrated GI practices by maintaining patients within the same diagnostic network.

By End User

Freestanding Gastroenterology ASCs

Freestanding GI ASCs represent the most strategically important customer class. More than 1,200 Medicare-billing ASCs were classified as single-specialty gastroenterology centers in 2024, representing roughly one-fifth of facilities billing Medicare. These centers prioritize procedure throughput, predictable device costs, equipment availability, standardized supply chains, low reprocessing downtime, and rapid service support.

Hospital Outpatient Endoscopy Departments

Hospital outpatient departments remain essential for higher-risk patients, complex therapeutic procedures, EUS, ERCP, and cases requiring immediate access to acute-care services. Their purchasing processes are generally more centralized and may involve value-analysis committees, enterprise contracts, cybersecurity review, infection prevention, capital planning, and system-wide vendor standardization.

Physician-Owned Gastroenterology Practices

Large GI practices are becoming sophisticated device buyers as consolidation increases. Their requirements span office diagnostics, procedure referral, revenue-cycle optimization, quality reporting, patient scheduling, and integration with affiliated ASCs. Manufacturers that can sell across multiple points in this continuum can obtain stronger account-level visibility.

Specialty Endoscopy Centers

Dedicated endoscopy centers focus on procedural specialization and high utilization. Their competitive advantage depends on maintaining reliable equipment, short turnover times, standardized clinical protocols, experienced staff, and favorable payer contracts. These centers are particularly receptive to technologies that produce measurable operational improvements.

Ambulatory Diagnostic and Integrated GI Networks

Integrated GI networks combine consultation, diagnostic testing, colonoscopy, upper endoscopy, pathology coordination, and follow-up care. Growth of these organizations is increasing demand for interoperable platforms and enterprise purchasing models rather than individual device transactions.

By Technology Type

Reusable Flexible Endoscopy

Reusable flexible endoscopy remains the dominant technology because high-volume centers can spread capital and reprocessing costs across thousands of procedures. Olympus, Fujifilm, and PENTAX Medical remain particularly influential in this installed-base-driven category. Future purchasing will increasingly depend on visualization capability, ergonomics, repair frequency, service turnaround, and platform interoperability.

Single-Use Endoscopy

Single-use colonoscopes, gastroscopes, duodenoscopes, and related visualization devices are expected to record above-market growth from a smaller installed base. Their value proposition centers on immediate availability, elimination of scope reprocessing, reduced cross-contamination concerns, predictable new-device condition, and simplified logistics in selected care environments.

AI-Assisted and Advanced Imaging

AI-supported lesion detection and enhanced visualization represent one of the fastest-growing technology layers. The economic case is strongest when systems integrate with existing equipment and require minimal disruption to physician workflow. Future competition will extend beyond polyp alerts into quality measurement, documentation, lesion characterization, and procedural analytics.

Electrosurgical and Advanced Therapeutic Technology

Energy platforms and therapeutic accessories are becoming increasingly relevant as outpatient centers manage more complex lesions. The value proposition combines precision, hemostasis, tissue management, speed, and the ability to complete therapy during a single endoscopic episode.

Connected Reprocessing and Workflow Technology

Connected workflow infrastructure includes automated reprocessing systems, traceability platforms, scope-management software, digital procedure documentation, equipment analytics, and inventory tools. These technologies address a practical challenge for ASC operators: increasing utilization without proportionally increasing labor and operational complexity.

By Clinical Application

Colorectal Cancer Screening and Surveillance

Colorectal cancer screening is the primary demand foundation for ambulatory GI devices. Screening beginning at age 45, aging demographics, surveillance of prior polyps, and follow-up of positive noninvasive tests support long-term colonoscopy volumes.

Gastroesophageal and Upper-GI Disorders

Reflux complications, Barrett’s esophagus, dysphagia, peptic disease, upper-GI bleeding, anemia, and suspected malignancy generate recurring demand for upper endoscopy and associated biopsy, dilation, imaging, and hemostatic products.

Gastrointestinal Bleeding and Lesion Management

Clips, injection technologies, coagulation tools, snares, retrieval systems, and closure devices support treatment of bleeding and mucosal lesions. Technology adoption is strongly influenced by reliability during urgent clinical scenarios.

Inflammatory and Functional Gastrointestinal Disorders

Patients with inflammatory bowel disease may require repeated endoscopic surveillance, while functional GI conditions create demand for pH, impedance, motility, and anorectal testing. These applications strengthen the recurring relationship between outpatient diagnostics and procedural gastroenterology.

Bariatric and Advanced Endoluminal Therapy

Endoscopic bariatric procedures and other advanced endoluminal interventions represent a higher-growth emerging opportunity. Development will depend on physician training, reimbursement, patient-selection protocols, procedural evidence, and the ability of ambulatory facilities to manage appropriate cases safely.

Regional Insights: Where the Market is Growing Fastest

The U.S. Ambulatory Gastroenterology Devices Market is geographically segmented into the South, West, Northeast, and Midwest. The South represents the largest revenue opportunity, while the West is expected to record the fastest growth through 2035.

South

The South generated an estimated USD 2.15 billion in 2025 and is projected to approach USD 5.75 billion by 2035, representing an estimated CAGR of approximately 10.34%.

The region combines the country’s largest population growth corridors with high ASC development, major Medicare populations, large gastroenterology groups, and increasing investment in outpatient medical infrastructure.

Texas is one of the country’s largest addressable ambulatory GI markets. Houston, Dallas–Fort Worth, Austin, and San Antonio support extensive physician-owned and health-system-affiliated endoscopy capacity. Population growth creates simultaneous demand for screening and chronic GI management.

Florida is particularly attractive because of its large older population and extensive ambulatory healthcare infrastructure. High Medicare utilization supports colonoscopy, upper endoscopy, surveillance, and therapeutic GI procedure demand.

Georgia has one of the country’s higher ASC concentrations and benefits from Atlanta’s expanding specialty-care ecosystem. Recent changes to certificate-of-need policy also improve the longer-term environment for selected outpatient facilities.

North Carolina combines fast population growth with major academic and integrated healthcare systems. Changes affecting ASC certificate-of-need requirements can improve outpatient procedural investment in larger counties.

South Carolina is becoming increasingly attractive following the reduction of certificate-of-need barriers for ambulatory surgery centers. Charleston, Columbia, Greenville, and other growth markets can support additional GI procedure capacity.

Virginia and Maryland have sophisticated physician networks, commercially insured populations, and proximity to major referral systems. Maryland is particularly notable for having one of the country’s highest ASC concentrations relative to its Medicare population.

Tennessee benefits from Nashville’s healthcare-services ecosystem and strong presence of multi-site ambulatory operators. Kentucky and West Virginia have meaningful digestive disease and colorectal screening needs but lower ASC penetration in several areas, creating a different opportunity focused on access and network development.

Alabama, Mississippi, Louisiana, and Arkansas combine meaningful disease burden with uneven specialist access, producing opportunities for standardized, cost-conscious GI platforms serving regional referral centers.

Oklahoma offers steady demand through Oklahoma City, Tulsa, and regional provider systems. Delaware is a smaller but commercially attractive market because of its insured population and proximity to major Mid-Atlantic health systems. The District of Columbia has sophisticated hospital-based care but comparatively limited freestanding ASC density.

The South should remain the largest regional market because Texas, Florida, Georgia, North Carolina, and other high-growth states continue adding both patients and outpatient procedural infrastructure.

West

The West represented approximately USD 1.39 billion in 2025 and is projected to reach around USD 3.90 billion by 2035, reflecting the fastest regional CAGR of approximately 10.87%.

California is the region’s largest market by a substantial margin. Its combination of population scale, academic medicine, large integrated delivery networks, technology adoption, and medical-device innovation makes the state particularly important for premium visualization, AI-assisted endoscopy, advanced therapeutic tools, and connected workflow technology.

Arizona is one of the country’s strongest ambulatory growth markets. Rapid population expansion, a growing retirement-age population, and high ASC availability support Scottsdale, Phoenix, Tucson, and surrounding markets.

Nevada and Utah benefit from population growth and relatively favorable outpatient development dynamics. Las Vegas, Reno, Salt Lake City, and emerging suburban markets provide opportunities for new endoscopy capacity.

Colorado combines population growth with sophisticated integrated health systems and comparatively strong ASC density. Denver and surrounding markets are attractive for advanced imaging and digitally connected procedural technology.

Washington and Oregon have mature provider organizations that frequently emphasize evidence-based procurement, enterprise interoperability, quality reporting, and efficient outpatient care.

Idaho, Wyoming, and Montana have smaller populations but relatively strong ASC availability in several areas. Opportunities center on regional referral models, efficient capital deployment, and minimizing equipment downtime where alternative facilities may be distant.

New Mexico faces greater geographic-access constraints, increasing the value of durable equipment, centralized specialist capacity, and appropriately distributed outpatient services.

Alaska has comparatively high ASC availability relative to its beneficiary population but unusual logistics and service requirements. Equipment reliability and supply-chain support can therefore materially affect purchasing.

Hawaii represents a smaller device market but benefits from concentrated healthcare delivery around Honolulu and major island-based referral networks.

The West is expected to gain share through premium imaging adoption, AI deployment, single-use technologies, population migration, and investment in ambulatory facilities.

Northeast

The Northeast accounted for approximately USD 1.34 billion in 2025 and is expected to reach around USD 3.40 billion by 2035, representing an estimated CAGR of approximately 9.76%.

New York is the region’s largest opportunity because of its population, high specialist density, major academic systems, and extensive gastroenterology networks. New York City supports advanced endoscopy, while suburban markets provide a substantial base for high-volume screening and surveillance.

New Jersey has a comparatively strong ambulatory surgery presence and favorable population density for physician-owned procedural networks. It is an important market for replacement endoscopy systems, advanced therapeutics, and enterprise purchasing.

Pennsylvania combines major metropolitan health systems in Philadelphia and Pittsburgh with extensive community-based GI care. The state’s mix supports both premium technology and cost-sensitive replacement demand.

Massachusetts is disproportionately influential because of its academic medical centers and innovation ecosystem. Advanced imaging, AI, clinical research, and new therapeutic technologies frequently receive early evaluation within the state.

Connecticut and Rhode Island provide compact, high-density markets where gastroenterology practices can achieve significant procedure volumes within relatively small geographic areas.

New Hampshire and Maine offer steady outpatient demand but greater geographic variation in specialist access outside major population centers.

Vermont has one of the lowest ASC concentrations relative to its Medicare beneficiary population, making its commercial structure substantially different from states such as New Jersey or Maryland. Growth is therefore more dependent on hospital outpatient and regional referral infrastructure.

The Northeast is unlikely to match the West’s growth rate because its demographics and provider infrastructure are more mature. However, high procedure complexity, commercially valuable patient populations, and early adoption of premium technology should preserve strong revenue per procedure.

Midwest

The Midwest represented approximately USD 1.02 billion in 2025 and is projected to reach around USD 2.60 billion by 2035, equivalent to an estimated CAGR of approximately 9.81%.

Illinois is the largest Midwest ambulatory GI opportunity. Chicago supports major academic centers, large independent gastroenterology groups, extensive suburban ASC networks, and high procedural density.

Ohio has substantial gastroenterology capacity across Cleveland, Columbus, Cincinnati, and regional markets. Its large health systems make enterprise contracting and vendor standardization particularly important.

Michigan supports strong demand around Detroit, Grand Rapids, and other population centers, while Indiana has an established ambulatory procedural market and attractive opportunities for physician-led GI centers.

Minnesota is strategically relevant because of its sophisticated health systems and broader medical-device ecosystem. Buyers are often receptive to technologies supported by strong clinical and operational evidence.

Wisconsin offers stable demand through Milwaukee, Madison, Green Bay, and integrated regional health systems.

Missouri combines two major medical markets in St. Louis and Kansas City with community-based procedural capacity across the state.

Kansas and Nebraska have relatively favorable ASC availability and can support regional procedural hubs serving both metropolitan and rural populations.

Iowa provides stable screening and diagnostic demand, although population dispersion makes geographic coverage important.

North Dakota and South Dakota are smaller device markets, but regional referral models create concentrated equipment demand at high-volume specialty centers.

Overall, the Midwest offers less explosive population growth than the South or West but remains attractive because of established gastroenterology networks, predictable replacement demand, strong healthcare institutions, and opportunities for technologies that deliver measurable cost-per-procedure benefits.

Key Market Players

The U.S. Ambulatory Gastroenterology Devices Competitive Landscape combines a concentrated endoscopy-platform market with a much broader ecosystem of therapeutic-device, disposable, reprocessing, functional-diagnostics, and emerging technology companies.

Key participants include:

Olympus Corporation
Boston Scientific Corporation
Medtronic
FUJIFILM Healthcare Americas Corporation
PENTAX Medical
Ambu A/S
STERIS plc
Cook Medical
CONMED Corporation
ERBE Elektromedizin GmbH / ERBE USA
Micro-Tech Endoscopy USA
Merit Medical Systems
Laborie Medical Technologies
Diversatek Healthcare
Creo Medical
EvoEndo, Inc.
EndoGastric Solutions
Taewoong Medical USA
SMART Medical Systems
Cosmo Pharmaceuticals
Iterative Health
EndoQuest Robotics
Johnson & Johnson MedTech
KARL STORZ

Competition differs substantially by category. Olympus, Fujifilm, and PENTAX have strong positions in reusable visualization infrastructure. Boston Scientific, Cook Medical, Medtronic, Micro-Tech Endoscopy, CONMED, ERBE, and Merit compete across therapeutic and procedural accessories. STERIS is strategically important to the reprocessing workflow, while Laborie and Diversatek participate in functional GI diagnostics.

Ambu and EvoEndo represent the disruptive single-use endoscopy opportunity. AI and digitally enabled gastroenterology broaden competition further, with companies such as Medtronic, Cosmo Pharmaceuticals, Iterative Health, and specialist developers competing to influence lesion detection, workflow analytics, and procedural quality.

Commercial advantage through 2035 will increasingly depend on breadth of account relationships. Vendors able to combine capital equipment, disposable accessories, physician training, service contracts, software, procedural support, and value-analysis evidence can capture a greater share of ASC expenditure than companies competing solely through individual product SKUs.

Recent Developments

The U.S. ambulatory gastroenterology market has entered an active replacement and innovation cycle.

Single-use endoscopy advanced materially in 2024 and 2025. Ambu received U.S. regulatory clearance for additional gastrointestinal endoscopy products, including a large-channel single-use gastroscope and second-generation single-use duodenoscope platform. These developments expand the clinical situations in which ambulatory providers can evaluate disposable endoscopy economics.

EvoEndo also advanced its single-use endoscopy platform through additional FDA clearances in 2025. While single-use technology will not immediately displace the reusable installed base in high-volume adult GI centers, continued regulatory activity indicates that disposable endoscopy is becoming a permanent competitive category rather than a temporary infection-control response.

Reusable visualization platforms are advancing simultaneously. Olympus received FDA clearance in 2025 for EZ1500-series gastroscope and colonoscope models incorporating extended-depth-of-field technology within the EVIS X1 ecosystem. The commercial implication is important: the reusable market is responding to disposable competition through improved image quality, ergonomics, workflow, and platform-level capability rather than price competition alone.

Fujifilm also continued expanding its U.S. endoscopy portfolio, including regulatory clearance of new 860-series colonoscope models and continued development of advanced enteroscopy and imaging technologies. In 2026, the company expanded its U.S. endoscopy logistics infrastructure with an approximately 18,000-square-foot New Jersey warehouse, highlighting the strategic importance of inventory availability and service support in the endoscopy market.

PENTAX Medical obtained additional U.S. clearances covering upper-GI scopes and colonoscopes, strengthening competitive activity among the established reusable endoscopy suppliers.

Training infrastructure is becoming another competitive dimension. In 2026, Olympus provided an endoscopy equipment award valued at more than USD 1 million to support ASGE training infrastructure, including multiple EVIS X1 systems. Such initiatives matter commercially because adoption of advanced endoscopy technologies depends heavily on physician familiarity and procedural training.

Reimbursement policy is also strengthening the ambulatory setting. CMS finalized a 2.6% ASC rate update for qualifying facilities for 2026 and expanded the ASC Covered Procedures List substantially. Although many newly eligible procedures are outside gastroenterology, the policy direction reinforces the broader U.S. transition toward outpatient procedural delivery.

The next stage of market development is therefore likely to be characterized by simultaneous competition across reusable platforms, disposable endoscopy, AI, therapeutic capability, reprocessing economics, and workflow integration.

Conclusion

The U.S. Ambulatory Gastroenterology Devices Market Size & Share is projected to expand from approximately USD 5.90 billion in 2025 to USD 15.65 billion by 2035, at a CAGR of 10.25% from 2026 to 2035.

The market’s growth foundation is unusually durable because it combines population aging, colorectal cancer screening, large recurring procedure volumes, expanding ASC infrastructure, outpatient site-of-care migration, advanced therapeutic endoscopy, and continuous equipment replacement.

Colonoscopy will remain the industry’s volume anchor, but the fastest value creation is likely to occur around AI-assisted endoscopy, advanced visualization, therapeutic accessories, endoluminal intervention, single-use technologies, connected reprocessing, and workflow platforms capable of improving procedure economics.

The South will remain the largest regional opportunity, supported by Texas, Florida, Georgia, North Carolina, and other rapidly growing states. The West is expected to register the fastest expansion, driven by California’s scale, strong ASC markets in Arizona and other states, population migration, and rapid adoption of technology-enabled care. The Northeast will retain a premium position because of its academic and specialist concentration, while the Midwest will provide dependable replacement and consumable demand.

For manufacturers and investors, the decisive question is not simply whether ambulatory gastroenterology procedure volumes will increase. The more consequential issue is which technologies can increase clinical value while fitting the narrow operational economics of an outpatient procedure center.

Successful companies will need to demonstrate that their products improve at least one measurable component of the ASC value equation: lesion detection, procedure completion, physician productivity, room turnover, infection prevention, staff efficiency, equipment uptime, inventory utilization, reimbursement capture, or total cost per case.

The U.S. ambulatory gastroenterology market is consequently evolving from a collection of endoscopy products into a high-throughput, digitally supported procedural ecosystem. Manufacturers capable of combining differentiated technology with defensible health economics and reliable nationwide service infrastructure are positioned to capture the strongest growth through 2035.

TABLE OF CONTENT

1. U.S. Ambulatory Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Gastroenterology Device Manufacturers
1.6.2. Endoscope Component and Contract Manufacturing Suppliers
1.6.3. Ambulatory Surgery Centers and Endoscopy Centers
1.6.4. Hospital Outpatient Gastroenterology Departments
1.6.5. Gastroenterology Practices and Physician-Owned Networks
1.6.6. Group Purchasing Organizations and Specialty Distributors
1.6.7. Reprocessing, Infection Prevention and Service Providers
1.6.8. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the U.S. ambulatory gastroenterology devices market boundary, research scope, methodology, assumptions, care-delivery ecosystem, and stakeholder structure so clients understand how market size, procedure demand, and device revenues are measured and validated.

2. U.S. Ambulatory Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Opportunity, 2025–2035
2.8. High-Growth Opportunity Areas
2.9. Ambulatory Procedure Migration Snapshot
2.10. Key Investment and Procurement Themes

What this section provides: This section provides decision-makers with a concise view of market size, CAGR, historical performance, forecast direction, ambulatory procedure migration, technology priorities, competitive intensity, and the most attractive commercial opportunities through 2035.

3. U.S. Ambulatory Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Ambulatory Gastroenterology and ASC Procedure Volumes
3.1.2. Rising Colorectal Cancer Screening and Surveillance Demand
3.1.3. Growth in the U.S. Population Aged 65 Years and Above
3.1.4. Shift of Gastrointestinal Procedures from Hospitals to Ambulatory Settings
3.1.5. Expansion of Advanced Therapeutic Endoscopy
3.1.6. Growing Adoption of AI-Assisted Endoscopy and Advanced Visualization
3.1.7. Increasing Focus on Infection Prevention and Endoscope Reprocessing
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Premium Endoscopy Platforms
3.2.2. ASC Reimbursement and Procedure-Margin Pressure
3.2.3. Endoscope Reprocessing and Infection-Control Complexity
3.2.4. Gastroenterologist, Anesthesia and Skilled Technician Workforce Constraints
3.2.5. Repair, Maintenance and Scope Downtime Costs
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Based Polyp and Lesion Detection
3.3.2. Single-Use Gastrointestinal Endoscopy Platforms
3.3.3. Advanced Endoscopic Resection and Closure Devices
3.3.4. Endoscopic Bariatric and Endoluminal Procedures
3.3.5. Connected Reprocessing and Scope Tracking
3.3.6. Expansion of Physician-Owned Gastroenterology Networks
3.3.7. New ASC Development in High-Growth U.S. States
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Ambulatory Gastroenterology Clinical Workflow Economics Analysis
3.7. ASC Capital Procurement Behavior Analysis
3.8. Procedure Room Throughput and Cost-per-Case Analysis
3.9. Reusable versus Single-Use Endoscopy Economics
3.10. Gastroenterology Workforce and Procedure Capacity Analysis

What this section provides: This section explains the clinical, procedural, economic, reimbursement, technology, and operational forces shaping U.S. ambulatory gastroenterology device demand and helps clients quantify both growth opportunities and execution risks.

4. U.S. Ambulatory Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Ambulatory Endoscopy Installed Base and Replacement Cycle Analysis
4.6. Impact of Digitalization and AI-Enabled Gastroenterology
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. CMS Reimbursement and ASC Coverage Landscape
4.10. Endoscope Reprocessing and Infection-Control Regulatory Environment
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Colorectal Cancer Screening and Public Health Initiatives
4.13. Impact of Escalating Geopolitical Tensions
4.14. ASC Value Analysis and Procurement Decision Framework
4.15. GPO and Multi-Site Gastroenterology Network Contracting Environment

What this section provides: This section provides a comprehensive assessment of regulation, reimbursement, pricing, supply chain, procedure economics, reprocessing requirements, digital adoption, and purchasing behavior affecting the U.S. ambulatory gastroenterology devices industry.

5. U.S. Ambulatory Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Endoscopy and Visualization Systems
5.1.2.1. Colonoscopes
5.1.2.2. Gastroscopes
5.1.2.3. Duodenoscopes
5.1.2.4. Enteroscopes
5.1.2.5. Endoscopic Ultrasound Systems
5.1.2.6. Video Processors and Light Sources
5.1.2.7. Medical-Grade Endoscopy Displays
5.1.2.8. Insufflation, Irrigation and Pump Systems
5.1.3. Endoscopic Accessories and Disposable Devices
5.1.3.1. Biopsy Forceps
5.1.3.2. Polypectomy Snares
5.1.3.3. Injection Needles
5.1.3.4. Retrieval Nets and Baskets
5.1.3.5. Guidewires
5.1.3.6. Valves, Tubing and Procedure Accessories
5.1.4. Therapeutic Gastroenterology Devices
5.1.4.1. Hemostasis Clips and Closure Devices
5.1.4.2. Electrosurgical Devices and Accessories
5.1.4.3. Dilation Balloons
5.1.4.4. Gastrointestinal Stents
5.1.4.5. Endoscopic Suturing Systems
5.1.4.6. Tissue Resection Devices
5.1.4.7. Endoscopic Bariatric Devices
5.1.5. Gastrointestinal Functional and Diagnostic Devices
5.1.5.1. Esophageal pH Monitoring Systems
5.1.5.2. Impedance Monitoring Systems
5.1.5.3. GI Motility Systems
5.1.5.4. Anorectal Manometry Systems
5.1.5.5. Breath Testing Systems
5.1.5.6. Capsule-Based Diagnostic Systems
5.1.6. Reprocessing and Infection-Prevention Devices
5.1.6.1. Automated Endoscope Reprocessors
5.1.6.2. Endoscope Drying and Storage Systems
5.1.6.3. Leak Testing Systems
5.1.6.4. Cleaning Verification Devices
5.1.6.5. Endoscope Tracking Systems
5.1.6.6. Cleaning Brushes and Reprocessing Accessories

What this section provides: This section identifies the ambulatory gastroenterology device categories generating the largest revenue pools and evaluates which equipment, consumables, therapeutic devices, diagnostic technologies, and reprocessing solutions are positioned for the strongest growth through 2035.

6. U.S. Ambulatory Gastroenterology Devices Market – By Procedure Type

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Colonoscopy
6.1.2.1. Screening Colonoscopy
6.1.2.2. Surveillance Colonoscopy
6.1.2.3. Diagnostic Colonoscopy
6.1.2.4. Colonoscopy with Biopsy
6.1.2.5. Colonoscopy with Polypectomy
6.1.3. Upper Gastrointestinal Endoscopy
6.1.3.1. Diagnostic EGD
6.1.3.2. EGD with Biopsy
6.1.3.3. EGD with Dilation
6.1.3.4. EGD with Hemostasis
6.1.4. ERCP, EUS and Pancreatobiliary Procedures
6.1.4.1. Endoscopic Retrograde Cholangiopancreatography
6.1.4.2. Endoscopic Ultrasound
6.1.4.3. Biliary and Pancreatic Stenting
6.1.4.4. Stone Extraction and Ductal Intervention
6.1.5. Advanced Endoscopic Therapy
6.1.5.1. Endoscopic Mucosal Resection
6.1.5.2. Complex Polypectomy
6.1.5.3. Endoscopic Defect Closure
6.1.5.4. Endoscopic Suturing
6.1.5.5. Endoscopic Hemostasis
6.1.5.6. Endoscopic Bariatric Procedures
6.1.6. GI Functional Testing and Office-Based Procedures
6.1.6.1. Esophageal pH Testing
6.1.6.2. GI Motility Testing
6.1.6.3. Anorectal Functional Testing
6.1.6.4. Breath Testing
6.1.6.5. Capsule-Based Evaluation

What this section provides: This section analyzes device demand by ambulatory GI procedure type and identifies procedure categories offering the strongest combination of volume growth, device utilization, reimbursement relevance, consumable intensity, and technology adoption.

7. U.S. Ambulatory Gastroenterology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Freestanding Gastroenterology Ambulatory Surgery Centers
7.1.2.1. Physician-Owned GI ASCs
7.1.2.2. Corporate/Management Company-Affiliated GI ASCs
7.1.2.3. Joint-Venture GI ASCs
7.1.3. Hospital Outpatient Endoscopy Departments
7.1.3.1. Academic Medical Center Outpatient Endoscopy Units
7.1.3.2. Community Hospital Outpatient Endoscopy Units
7.1.3.3. Integrated Delivery Network Outpatient Facilities
7.1.4. Physician-Owned Gastroenterology Practices
7.1.4.1. Independent Gastroenterology Groups
7.1.4.2. Multi-State Gastroenterology Platforms
7.1.4.3. Private Equity-Backed Gastroenterology Networks
7.1.5. Specialty Endoscopy Centers
7.1.5.1. Screening-Focused Endoscopy Centers
7.1.5.2. Advanced Therapeutic Endoscopy Centers
7.1.6. Ambulatory Diagnostic and Integrated GI Networks
7.1.6.1. GI Functional Diagnostic Centers
7.1.6.2. Integrated Consultation and Procedure Networks

What this section provides: This section explains how device purchasing and procedural adoption vary across freestanding ASCs, hospital outpatient departments, physician groups, specialty endoscopy centers, and integrated gastroenterology networks.

8. U.S. Ambulatory Gastroenterology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Reusable Flexible Endoscopy
8.1.2.1. Conventional High-Definition Endoscopy
8.1.2.2. Enhanced Visualization Endoscopy
8.1.2.3. Reusable Therapeutic Endoscopy
8.1.3. Single-Use Endoscopy
8.1.3.1. Single-Use Gastroscopes
8.1.3.2. Single-Use Colonoscopes
8.1.3.3. Single-Use Duodenoscopes
8.1.3.4. Other Disposable Endoscopic Platforms
8.1.4. AI-Assisted and Advanced Imaging Technologies
8.1.4.1. Computer-Aided Detection
8.1.4.2. Computer-Aided Diagnosis and Characterization
8.1.4.3. Image Enhancement Technologies
8.1.4.4. AI-Enabled Quality and Workflow Analytics
8.1.5. Electrosurgical and Advanced Therapeutic Technologies
8.1.5.1. Electrosurgical Generators
8.1.5.2. Tissue Resection Technologies
8.1.5.3. Endoscopic Closure Technologies
8.1.5.4. Endoscopic Suturing Technologies
8.1.6. Connected Reprocessing and Workflow Technologies
8.1.6.1. Automated Reprocessing Systems
8.1.6.2. Digital Scope Tracking
8.1.6.3. Procedure Documentation and Workflow Integration
8.1.6.4. Equipment and Inventory Analytics

What this section provides: This section evaluates the technology platforms reshaping ambulatory gastroenterology, including reusable and disposable endoscopy, AI-assisted visualization, advanced therapeutic technologies, and digitally connected reprocessing and workflow systems.

9. U.S. Ambulatory Gastroenterology Devices Market – By Clinical Application

9.1. Overview
9.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)
9.1.2. Colorectal Cancer Screening and Surveillance
9.1.2.1. Average-Risk Screening
9.1.2.2. High-Risk Surveillance
9.1.2.3. Post-Polypectomy Surveillance
9.1.2.4. Follow-Up of Positive Stool-Based Screening Tests
9.1.3. Gastroesophageal and Upper-GI Disorders
9.1.3.1. Gastroesophageal Reflux Disease
9.1.3.2. Barrett’s Esophagus
9.1.3.3. Dysphagia and Esophageal Disorders
9.1.3.4. Peptic Ulcer and Upper-GI Disease
9.1.4. Gastrointestinal Bleeding and Lesion Management
9.1.4.1. Polyp and Mucosal Lesion Management
9.1.4.2. Upper-GI Bleeding
9.1.4.3. Lower-GI Bleeding
9.1.4.4. Endoscopic Hemostasis and Closure
9.1.5. Inflammatory and Functional Gastrointestinal Disorders
9.1.5.1. Inflammatory Bowel Disease Surveillance
9.1.5.2. Functional Esophageal Disorders
9.1.5.3. GI Motility Disorders
9.1.5.4. Anorectal Disorders
9.1.6. Bariatric and Advanced Endoluminal Therapy
9.1.6.1. Endoscopic Sleeve Gastroplasty
9.1.6.2. Endoscopic Revision Procedures
9.1.6.3. Endoluminal Suturing and Closure
9.1.6.4. Other Advanced Therapeutic Applications

What this section provides: This section analyzes ambulatory gastroenterology device demand by major clinical use case and identifies applications with high screening volumes, recurring surveillance requirements, therapeutic-device intensity, and emerging outpatient treatment potential.

10. U.S. Ambulatory Gastroenterology Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Gastroenterology Procedure Volume and ASC Infrastructure Analysis
10.1.4. Regional Colorectal Screening and Digestive Disease Demand Analysis
10.1.5. Regional Reimbursement and ASC Development Dynamics
10.1.6. Regional Gastroenterologist Density and Procedure Capacity Analysis
10.1.7. Regional Procurement and Device Replacement Trends

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Ambulatory Gastroenterology Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Ambulatory Gastroenterology Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Ambulatory Gastroenterology Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Ambulatory Gastroenterology Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level market intelligence across all 50 U.S. states, enabling clients to identify high-volume gastroenterology markets, ASC development hotspots, colorectal screening opportunities, device replacement demand, technology-adoption centers, and state-level commercial priorities.

11. U.S. Ambulatory Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.2.1. Endoscopy Platform Leadership
11.2.2. Therapeutic Device Portfolio Strength
11.2.3. Ambulatory Market Penetration
11.2.4. AI and Digital Gastroenterology Capability
11.2.5. Single-Use Endoscopy Positioning
11.2.6. Reprocessing and Infection-Prevention Capability
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Olympus Corporation
11.4.2. Boston Scientific Corporation
11.4.3. Medtronic
11.4.4. FUJIFILM Healthcare Americas Corporation
11.4.5. PENTAX Medical
11.4.6. Ambu A/S
11.4.7. STERIS plc
11.4.8. Cook Medical
11.4.9. CONMED Corporation
11.4.10. ERBE Elektromedizin GmbH / ERBE USA
11.4.11. Micro-Tech Endoscopy USA
11.4.12. Merit Medical Systems
11.4.13. Laborie Medical Technologies
11.4.14. Diversatek Healthcare
11.4.15. Creo Medical
11.4.16. EvoEndo, Inc.
11.4.17. EndoGastric Solutions
11.4.18. Taewoong Medical USA
11.4.19. SMART Medical Systems
11.4.20. Cosmo Pharmaceuticals
11.4.21. Iterative Health
11.4.22. EndoQuest Robotics
11.4.23. Johnson & Johnson MedTech
11.4.24. KARL STORZ
11.4.25. Bracco Diagnostics / ACIST Medical Systems

11.5. Company Profile Framework
11.5.1. Company Overview
11.5.2. Ambulatory Gastroenterology Device Portfolio
11.5.3. U.S. Market Strategy
11.5.4. Financial and Commercial Positioning
11.5.5. Product Pipeline and Innovation Strategy
11.5.6. FDA Regulatory Updates
11.5.7. Partnerships, Acquisitions and Strategic Alliances
11.5.8. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, ambulatory account exposure, technology differentiation, innovation direction, and strategic intelligence on leading U.S. gastroenterology device companies.

12. U.S. Ambulatory Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Polyp Detection and Characterization
12.2.2. Single-Use Gastrointestinal Endoscopy
12.2.3. Advanced Therapeutic Endoscopy
12.2.4. Robotic and Computer-Assisted Endoluminal Intervention
12.2.5. Connected Endoscope Reprocessing and Tracking
12.2.6. Digital Procedure Quality Analytics
12.3. Future of Ambulatory Colonoscopy and Screening
12.4. Advanced GI Procedure Migration to Ambulatory Settings
12.5. Emerging Business Trends
12.6. Gastroenterology Practice Consolidation Impact
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. High-Growth Device and Procedure Opportunity Matrix
12.10. U.S. ASC Expansion Opportunity Through 2035

What this section provides: This section prepares clients for future technology shifts, ASC expansion, procedure migration, gastroenterology practice consolidation, investment opportunities, and alternative adoption scenarios through 2035.

13. U.S. Ambulatory Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Gastroenterology Device Manufacturers
13.2. Recommendations for Ambulatory Surgery Centers
13.3. Recommendations for Gastroenterology Practices and Physician Groups
13.4. Recommendations for Hospitals and Integrated Delivery Networks
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. ASC Contracting and Account Penetration Strategy
13.11. Reusable versus Single-Use Portfolio Strategy
13.12. AI and Digital Gastroenterology Commercialization Strategy
13.13. State-Level Market Prioritization Strategy
13.14. Clinical Evidence and Health-Economic Value Proposition Strategy

What this section provides: This section converts market intelligence into actionable recommendations for device commercialization, ASC penetration, portfolio positioning, state-level expansion, distribution strategy, investment decisions, and competitive differentiation.

14. U.S. Ambulatory Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Estimation Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope, methodological and forecasting limitations, regulatory and reimbursement information boundaries, third-party data use, and legal terms.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Ambulatory Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Ambulatory Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Ambulatory Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Ambulatory Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Ambulatory Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Ambulatory Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Ambulatory Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Ambulatory Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Ambulatory Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Ambulatory Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Ambulatory Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Ambulatory Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Ambulatory Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Ambulatory Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Ambulatory Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Ambulatory Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Ambulatory Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Ambulatory Gastroenterology Devices Market: ASC Capital Procurement Behavior Matrix
TABLE 20: U.S. Ambulatory Gastroenterology Devices Market: Procedure Room Throughput and Cost-per-Case Analysis
TABLE 21: U.S. Ambulatory Gastroenterology Devices Market: Reusable vs. Single-Use Endoscopy Economics
TABLE 22: U.S. Ambulatory Gastroenterology Devices Market: Gastroenterology Workforce and Procedure Capacity Analysis
TABLE 23: U.S. Ambulatory Gastroenterology Devices Market: PESTEL Analysis
TABLE 24: U.S. Ambulatory Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Ambulatory Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Ambulatory Gastroenterology Devices Market: Value Chain Analysis
TABLE 27: U.S. Ambulatory Gastroenterology Devices Market: Supply Chain Analysis
TABLE 28: U.S. Ambulatory Gastroenterology Devices Market: Installed Base and Replacement Cycle Analysis
TABLE 29: U.S. Ambulatory Gastroenterology Devices Market: Digitalization and AI-Enabled Gastroenterology Impact
TABLE 30: U.S. Ambulatory Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 31: U.S. Ambulatory Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Ambulatory Gastroenterology Devices Market: CMS Reimbursement and ASC Coverage Landscape
TABLE 33: U.S. Ambulatory Gastroenterology Devices Market: Endoscope Reprocessing and Infection-Control Landscape
TABLE 34: U.S. Ambulatory Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 35: U.S. Ambulatory Gastroenterology Devices Market: ASC Value Analysis and Procurement Decision Framework
TABLE 36: U.S. Ambulatory Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Category
TABLE 38: U.S. Ambulatory Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 39: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 40: Endoscopy and Visualization Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: Endoscopic Accessories and Disposable Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Therapeutic Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Gastrointestinal Functional, Diagnostic, Reprocessing and Infection-Prevention Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Ambulatory Gastroenterology Devices Market: Procedure Type Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 46: U.S. Ambulatory Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 47: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 48: Colonoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Upper Gastrointestinal Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: ERCP, EUS and Pancreatobiliary Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Advanced Endoscopic Therapy and GI Functional Testing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Ambulatory Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 53: Segment Dashboard; Definition and Scope, by End User
TABLE 54: U.S. Ambulatory Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 55: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 56: Freestanding Gastroenterology ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Hospital Outpatient Endoscopy Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Physician-Owned Gastroenterology Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Specialty Endoscopy Centers and Integrated GI Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Ambulatory Gastroenterology Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Ambulatory Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: Reusable Flexible Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Single-Use Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: AI-Assisted and Advanced Imaging Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Electrosurgical, Therapeutic and Connected Workflow Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Ambulatory Gastroenterology Devices Market: Clinical Application Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 70: U.S. Ambulatory Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 71: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 72: Colorectal Cancer Screening and Surveillance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Gastroesophageal and Upper-GI Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Gastrointestinal Bleeding, Lesion Management and Inflammatory GI Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Bariatric and Advanced Endoluminal Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Ambulatory Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Region
TABLE 78: U.S. Ambulatory Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 79: U.S. Ambulatory Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 80: U.S. Ambulatory Gastroenterology Devices Market: Regional ASC Infrastructure and Procedure Capacity Analysis
TABLE 81: West Region U.S. Ambulatory Gastroenterology Devices Market: Regional Overview and Trends
TABLE 82: West Region: Key Manufacturers and Procurement Ecosystem
TABLE 83: West Region Market, by State, 2021–2035 (US$ Billion)
TABLE 84: West Region Market, by Product Category, Procedure Type, End User, Technology Type and Clinical Application, 2021–2035
TABLE 85: California Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Washington Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Arizona Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Colorado Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Oregon Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Utah Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Nevada Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: New Mexico Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Idaho Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Montana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Wyoming Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Alaska Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Hawaii Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Northeast Region U.S. Ambulatory Gastroenterology Devices Market: Regional Overview and Trends
TABLE 99: Northeast Region: Key Manufacturers and Procurement Ecosystem
TABLE 100: Northeast Region Market, by State, 2021–2035 (US$ Billion)
TABLE 101: Northeast Region Market, by Product Category, Procedure Type, End User, Technology Type and Clinical Application, 2021–2035
TABLE 102: New York Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Massachusetts Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: New Jersey Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Pennsylvania Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Connecticut Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Maine Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Vermont Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: New Hampshire Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Rhode Island Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Delaware Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: South Region U.S. Ambulatory Gastroenterology Devices Market: Regional Overview and Trends
TABLE 113: South Region: Key Manufacturers and Procurement Ecosystem
TABLE 114: South Region Market, by State, 2021–2035 (US$ Billion)
TABLE 115: South Region Market, by Product Category, Procedure Type, End User, Technology Type and Clinical Application, 2021–2035
TABLE 116: Texas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Florida Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Georgia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: North Carolina Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Tennessee Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: South Carolina Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Alabama Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Mississippi Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Louisiana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Arkansas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Kentucky Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Oklahoma Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Virginia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Maryland Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: West Virginia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Midwest Region U.S. Ambulatory Gastroenterology Devices Market: Regional Overview and Trends
TABLE 132: Midwest Region: Key Manufacturers and Procurement Ecosystem
TABLE 133: Midwest Region Market, by State, 2021–2035 (US$ Billion)
TABLE 134: Midwest Region Market, by Product Category, Procedure Type, End User, Technology Type and Clinical Application, 2021–2035
TABLE 135: Illinois Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Ohio Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Michigan Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Minnesota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Indiana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Wisconsin Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Missouri Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Iowa Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Kansas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Nebraska Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: North Dakota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: South Dakota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: U.S. Ambulatory Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 148: U.S. Ambulatory Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 149: U.S. Ambulatory Gastroenterology Devices Market: Company Positioning Matrix
TABLE 150: U.S. Ambulatory Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 151: U.S. Ambulatory Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 152: Olympus Corporation: Company Profile
TABLE 153: Boston Scientific Corporation: Company Profile
TABLE 154: Medtronic: Company Profile
TABLE 155: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 156: PENTAX Medical: Company Profile
TABLE 157: Ambu A/S: Company Profile
TABLE 158: STERIS plc: Company Profile
TABLE 159: Cook Medical: Company Profile
TABLE 160: CONMED Corporation: Company Profile
TABLE 161: ERBE Elektromedizin / ERBE USA: Company Profile
TABLE 162: Micro-Tech Endoscopy USA: Company Profile
TABLE 163: Merit Medical Systems: Company Profile
TABLE 164: Laborie Medical Technologies: Company Profile
TABLE 165: Diversatek Healthcare: Company Profile
TABLE 166: Creo Medical: Company Profile
TABLE 167: EvoEndo, Inc.: Company Profile
TABLE 168: EndoGastric Solutions: Company Profile
TABLE 169: Taewoong Medical USA: Company Profile
TABLE 170: SMART Medical Systems: Company Profile
TABLE 171: Cosmo Pharmaceuticals: Company Profile
TABLE 172: Iterative Health: Company Profile
TABLE 173: EndoQuest Robotics: Company Profile
TABLE 174: Johnson & Johnson MedTech: Company Profile
TABLE 175: KARL STORZ: Company Profile
TABLE 176: Bracco Diagnostics / ACIST Medical Systems: Company Profile
TABLE 177: U.S. Ambulatory Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 178: U.S. Ambulatory Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 179: AI-Assisted Endoscopy Opportunity Assessment
TABLE 180: Single-Use Gastrointestinal Endoscopy Adoption Outlook
TABLE 181: Advanced Therapeutic Endoscopy Opportunity Matrix
TABLE 182: Ambulatory Procedure Migration Outlook, 2026–2035
TABLE 183: U.S. Ambulatory Gastroenterology Devices Market: Emerging Business Trends
TABLE 184: Business Opportunities for Startups and Existing Players
TABLE 185: Investment Prioritization Matrix
TABLE 186: Strategic Recommendations for Gastroenterology Device Manufacturers
TABLE 187: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 188: Strategic Recommendations for Gastroenterology Practices and Physician Groups
TABLE 189: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 190: Strategic Recommendations for Investors and Private Equity Firms
TABLE 191: Strategic Recommendations for Distributors and Channel Partners
TABLE 192: Strategic Recommendations for New Entrants and Startups
TABLE 193: U.S. Ambulatory Gastroenterology Devices Market: Go-to-Market Strategy Considerations
TABLE 194: Product Positioning, Portfolio Expansion and State-Level Market Prioritization Guidance
TABLE 195: U.S. Ambulatory Gastroenterology Devices Market: Scope Limitation
TABLE 196: U.S. Ambulatory Gastroenterology Devices Market: Data Use Limitation
TABLE 197: U.S. Ambulatory Gastroenterology Devices Market: Forecasting Limitation
TABLE 198: U.S. Ambulatory Gastroenterology Devices Market: Market Estimation Limitation
TABLE 199: U.S. Ambulatory Gastroenterology Devices Market: Legal Disclaimer
TABLE 200: U.S. Ambulatory Gastroenterology Devices Market: Third-Party Data Disclaimer
TABLE 201: U.S. Ambulatory Gastroenterology Devices Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Ambulatory Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Ambulatory Gastroenterology Devices Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Framework
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. Ambulatory Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Ambulatory Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Ambulatory Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. Ambulatory Gastroenterology Devices Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Ambulatory Gastroenterology Clinical Workflow Economics Framework
FIGURE 12: ASC Capital Procurement Decision Framework
FIGURE 13: Procedure Room Throughput and Cost-per-Case Framework
FIGURE 14: Reusable vs. Single-Use Endoscopy Economic Comparison
FIGURE 15: Gastroenterology Workforce and Procedure Capacity Outlook
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Ambulatory Endoscopy Installed Base and Replacement Cycle
FIGURE 21: FDA Regulatory and CMS Reimbursement Framework
FIGURE 22: Endoscope Reprocessing and Infection-Control Workflow
FIGURE 23: ASC Value Analysis and Procurement Decision Framework
FIGURE 24: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Endoscopy and Visualization Systems Market Size Forecast, 2021–2035
FIGURE 27: Endoscopic Accessories and Disposable Devices Market Size Forecast, 2021–2035
FIGURE 28: Therapeutic Gastroenterology Devices Market Size Forecast, 2021–2035
FIGURE 29: Gastrointestinal Functional and Diagnostic Devices Market Size Forecast, 2021–2035
FIGURE 30: Reprocessing and Infection-Prevention Devices Market Size Forecast, 2021–2035
FIGURE 31: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 32: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 33: Colonoscopy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 34: Upper Gastrointestinal Endoscopy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 35: ERCP and EUS Procedure Device Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 36: Advanced Endoscopic Therapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: GI Functional Testing Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 39: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: Freestanding Gastroenterology ASCs Market Size Forecast, 2021–2035
FIGURE 41: Hospital Outpatient Endoscopy Departments Market Size Forecast, 2021–2035
FIGURE 42: Physician-Owned Gastroenterology Practices Market Size Forecast, 2021–2035
FIGURE 43: Specialty Endoscopy Centers Market Size Forecast, 2021–2035
FIGURE 44: Integrated GI Networks Market Size Forecast, 2021–2035
FIGURE 45: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 46: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 47: Reusable Flexible Endoscopy Market Size Forecast, 2021–2035
FIGURE 48: Single-Use Endoscopy Market Size Forecast, 2021–2035
FIGURE 49: AI-Assisted and Advanced Imaging Technologies Market Size Forecast, 2021–2035
FIGURE 50: Electrosurgical and Advanced Therapeutic Technologies Market Size Forecast, 2021–2035
FIGURE 51: Connected Reprocessing and Workflow Technologies Market Size Forecast, 2021–2035
FIGURE 52: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 53: Clinical Application Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 54: Colorectal Cancer Screening and Surveillance Market Size Forecast, 2021–2035
FIGURE 55: Gastroesophageal and Upper-GI Disorders Market Size Forecast, 2021–2035
FIGURE 56: Gastrointestinal Bleeding and Lesion Management Market Size Forecast, 2021–2035
FIGURE 57: Inflammatory and Functional GI Disorders Market Size Forecast, 2021–2035
FIGURE 58: Bariatric and Advanced Endoluminal Therapy Market Size Forecast, 2021–2035
FIGURE 59: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 60: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: West Region Market Share Analysis by State, 2025
FIGURE 62: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 63: West Region ASC Infrastructure and Procedure Capacity
FIGURE 64: California Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 65: Washington Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 66: Arizona Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 67: Colorado Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 68: Oregon Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 69: Utah Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 70: Nevada Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 71: New Mexico Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 72: Idaho Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 73: Montana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 74: Wyoming Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 75: Alaska Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 76: Hawaii Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 77: Northeast Region Market Share Analysis by State, 2025
FIGURE 78: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 79: Northeast Region ASC Infrastructure and Procedure Capacity
FIGURE 80: New York Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 81: Massachusetts Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 82: New Jersey Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 83: Pennsylvania Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 84: Connecticut Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 85: Maine Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 86: Vermont Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 87: New Hampshire Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 88: Rhode Island Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 89: Delaware Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 90: South Region Market Share Analysis by State, 2025
FIGURE 91: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 92: South Region ASC Infrastructure and Procedure Capacity
FIGURE 93: Texas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 94: Florida Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 95: Georgia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 96: North Carolina Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 97: Tennessee Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 98: South Carolina Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 99: Alabama Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 100: Mississippi Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 101: Louisiana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 102: Arkansas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 103: Kentucky Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 104: Oklahoma Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 105: Virginia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 106: Maryland Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 107: West Virginia Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 108: Midwest Region Market Share Analysis by State, 2025
FIGURE 109: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 110: Midwest Region ASC Infrastructure and Procedure Capacity
FIGURE 111: Illinois Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 112: Ohio Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 113: Michigan Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 114: Minnesota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 115: Indiana Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 116: Wisconsin Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 117: Missouri Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 118: Iowa Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 119: Kansas Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 120: Nebraska Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 121: North Dakota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 122: South Dakota Ambulatory Gastroenterology Devices Market Size and Forecast, 2021–2035
FIGURE 123: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 124: Company Positioning Matrix
FIGURE 125: Key Player Product Portfolio Benchmarking
FIGURE 126: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 127: U.S. Ambulatory Gastroenterology Device Innovation Roadmap
FIGURE 128: Future Market Scenario Analysis, 2026–2035
FIGURE 129: Disruptive Technologies Impact Matrix
FIGURE 130: AI-Assisted Endoscopy Adoption Roadmap
FIGURE 131: Single-Use Endoscopy Adoption Roadmap
FIGURE 132: Advanced Therapeutic Endoscopy Opportunity Map
FIGURE 133: Ambulatory GI Procedure Migration Roadmap, 2026–2035
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: Strategic Growth Roadmap for U.S. Ambulatory Gastroenterology Device Companies
FIGURE 136: Go-to-Market Strategy Framework
FIGURE 137: Product Positioning and Portfolio Expansion Framework
FIGURE 138: State-Level Commercial Prioritization Framework
FIGURE 139: Report Scope, Methodological Limitations and Disclaimer Framework